Table 2 VLP yield and thermostability

From: Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines

Expression System

Serotype

VLP Yield (D Ag/100 mL Culture)

Vaccine Doses (per 100 mL Culture)

Thermostability (Temp °C 50% D Ag loss)

Thermostability vs WT Empty Capsids (°C)

Thermostability vs IPV (°C)

D:C Ratio

Mammalian

PV1-SC6b

26.3

0.8

49

+13

0

D>C

PV2-SC6b

76.5

9

57

+15

+5

-

PV3-SC8

698

25

62

+29

+10

D>>C

Baculovirus

PV1-SC6b

398 to 969

12–30

44

+8

−5

D only

PV2-SC6b

127 to 138a

16–18

49.5

+7.5

2.5

-

PV3-SC8

935 to 2267

33–81

60

+27

+ 8

D only

Yeast

PV1-SC6b

1030 (±40)

32

43.5

+7.5

−5.5

D>>C

PV2-SC6b

69 (±12)

8

52.5

+10.5

+0.5

-

PV3-SC8

745 (±65)

26

55

+22

+3

D>C

Plant*

PV1-SC6b

235 (±71)

7

44

+8

−5

D>C

PV2-SC6b

1.3 (±0.4)

0.16

53

+11

+1

-

PV3-SC8

180 (±28)

6

54

+21

+2

D>C

  1. *D Ag and Vaccine doses per 10 g leaf material.
  2. aBefore codon optimisation 63, after Sf9 codon optimisation 138 DAg/100 ml.